KevinPRosenbachMD

PubMed

• 1 citations
  Real-World Evidence of Tolerability of 20% Subcutaneous Immunoglobulin Treatment.
  Kevin Rosenbach, Michelle Park, Marie Sanchirico, Oliseyenum Nwose, Kenneth Paris
  Journal of Clinical Immunology. 2023-07-01
• ASCENIV utilization in a primary immunodeficiency patient with recurrent viral infections.
  Kevin P Rosenbach, Benjamin N Greener, John T Rosenbach, Gene A Wetzstein
  Immunological Medicine. 2023-03-01

Journal Articles

• Dermatomyositis  
  Rosenbach KP, Truitt C, Kanik K, Adelman H, Hospital Practice, 1/15/1997

Books/Book Chapters

• Conn's Medical Diagnosis and Treatment. 51st Anniversary Edition 
  Chapter: Diagnosis and Treatment of Insect Sting Hypersensitivity. 
  Lockey RF, R Nelson, Jr., KP Rosenbach1998
• Conn's Medical Diagnosis and Treatment. 50th Anniversary Edition 
  Chapter: Diagnosis and Treatment of Insect Sting Hypersensitivity. 
  Lockey RF, (KP Rosenbach)1997
• MedCharts-Pharmacology 
  Rosenbach KP, MDILOC, Inc. Publishers, Granville, OHEdition 1st,1993
• Proceedings of the XVIth International Congress of Allergology and Clinical Immunology. Progress in Allergy and Clinical Immunology, Vol. 4 
  Chapter: Diagnosis and Treatment of Insect Sting Hypersensitivity. 
  Page 73 - 80Lockey RF, KP RosenbachHogrefe & Hubner Publishers, Seattle
• Join now to see all

Abstracts/Posters

• Real World Use of Recombinant Human Hyaluronidase-facilitated Subcutaneous Infusion of Immunoglobulin (Ig) (IGHy) in Patients with Primary Immunodeficiency Disorders (...
  KP Rosenbach, FAAIS (Florida Allergy, Asthma and Immunology Society), Orlando, FL, 1/22/2016
• Real World Use of Recombinant Human Hyaluronidase-facilitated Subcutaneous Infusion of Immunoglobulin (Ig) (IGHy) in Patients with Primary Immunodeficiency Disorders (...
  KP Rosenbach, CIS (Clinical Immunology Society), Boston, MA, 1/14/2016
• Real World Use of Recombinant Human Hyaluronidase-facilitated Subcutaneous Infusion of Immunoglobulin (Ig) (IGHy) in Patients with Primary Immunodeficiency Disorders (...
  KP Rosenbach, AAAAI (American Academy of Allergy, Asthma, and Immunology), Los Angeles, CA, 1/6/2016
• Real World Use of Recombinant Human Hyaluronidase-facilitated Subcutaneous Infusion of Immunoglobulin (Ig) (IGHy) in Patients with Primary Immunodeficiency Disorders (...
  KP Rosenbach, IFIR, Berlin, Germany, 1/9/2015
• Long-Term use of Budesonide? Turbuhaler? in Corticosteroid Dependant Asthma.
  KP Rosenbach, DK Ledford, AAAAI (American Academy of Allergy, Asthma, and Immunology) '97 Meeting, San Francisco, CA, 1/25/1997
• A Case of Small Vessel Vasculitis Attributed to Technetium-99m Sestamibi.
  KP Rosenbach, DK Ledford, AAAAI (American Academy of Allergy, Asthma, and Immunology) '97 Meeting, San Francisco, CA, 1/24/1997
• Long-Term use of Budesonide? Turbuhaler? in Corticosteroid Dependant Asthma.
  KP Rosenbach, DK Ledford, ICACI '97, Cancun, Mexico, 1/21/1997
• A Simple Outpatient Desensitization Protocol for Aspirin Triad Subjects.
  KP Rosenbach, H Windom, RF Lockey, ICACI '97, Cancun, Mexico, 1/20/1997
• A Case of Small Vessel Vasculitis Attributed to Technetium-99m Sestamibi.
  KP Rosenbach, MD and DK Ledford, MD, University of South Florida Research Day, 1/17/1995
• Join now to see all

Lectures

• HyQvia, Cuvitru, Immunology 
  1/1/2018
• Recognizing and Understand Primary Immune Deficiency Disease 
  1/1/2018
• Recognizing Common Comorbid Diseases Associated with PID 
  1/1/2018
• Antihistamines and Allergic Disease. 
  1/24/1997
• Long Term Use of Budesonide Turbuhaler? in Corticosteroid Dependent Asthma. 
  Cancun, Mexico - 1/21/1997
• AIDS & Treatment of HIV Disease. 
  1/18/1997
• Osteoporosis & Asthma. 
  1/13/1997
• Join now to see all

Other

• Interferon-alpha Producing Cells Provide Accessory Function for the Lysis of HSV-1 Infected Human Fibroblasts by Natural Killer Effector Cells. 
  Rosenbach KP, Fitzgerald-Bocarsly P, UMDNJ Student Research Program, pp 101
  1/1/1989